Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 6, Issue 12, pp. 1499-1510
PubMed
Published By
Print ISSN
Online ISSN
History
- Received January 10, 2018
- Revision received July 27, 2018
- Accepted October 16, 2018
- Published first October 23, 2018.
Article Versions
- Previous version (October 23, 2018 - 07:09).
- Previous version (November 13, 2018 - 07:03).
- You are viewing the most recent version of this article.
Copyright & Usage
©2018 American Association for Cancer Research.
Author Information
- 1The Research Institute at Nationwide Children's Hospital Center for Childhood Cancer and Blood Disorders, The Ohio State University, Columbus, Ohio.
- 2Nationwide Children's Hospital, Department of Pediatrics, Division of Pediatric Infectious Diseases, The Ohio State University, Columbus, Ohio.
- 3The Ohio State University, Columbus, Ohio.
- ↵*Corresponding Author:
Kevin A. Cassady, Center for Childhood Cancer and Blood Diseases, The Research Institute at Nationwide Children's Hospital, The Ohio State University College of Medicine, 700 Children's Drive, Columbus, Ohio 43205. Phone: 614-722-2798; Fax: 614-722-2798; E-mail: Kevin.Cassady{at}Nationwidechildrens.org
December 2018
Volume 6, Issue 12
Volume 6, Issue 12
Combination Therapy Using Ruxolitinib and Oncolytic HSV Renders Resistant MPNSTs Susceptible to Virotherapy
Jump to section
Advertisement